{"slug":"vip-nerve-damage","verification":{"valid":true,"entries":2,"head":"fd5ed8c2c7ecb6cdfeede618332a5bcd764bb30b51dd75d6db66f29f06e4c475"},"energy":{"passes":2,"tokens_in":14476,"tokens_out":2637,"tokens_total":17113,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"fd5ed8c2c7ecb6cdfeede618332a5bcd764bb30b51dd75d6db66f29f06e4c475"},"provenance":[{"ts":"2026-06-29T22:29:34.721Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Vip for Nerve Damage\nSlug: vip-nerve-damage\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"vip\",\"name\":\"VIP\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"vip\",\"name\":\"VIP\",\"section_title\":\"Why VIP might help you\",\"layer\":\"immune / autonomic\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **VIP** → immune / autonomic\",\"section_headings\":[\"What's breaking down\",\"Why VIP might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from peptide_chains / drug_chains.\",\"weig","response":"{\n  \"slug\": \"vip-nerve-damage\",\n  \"title\": \"VIP for Nerve Damage: Preclinical Signals on Vasoactive Intestinal Peptide\",\n  \"body\": \"## What's breaking down\\nNerve damage often involves axonal degeneration, myelin loss, and disrupted signal transmission. Inflammatory cells can invade the injury site and slow repair. Autonomic nerves that control blood flow and local immune tone may also falter after injury. When repair pathways lag behind ongoing breakdown, symptoms persist. VIP is studied mainly for its roles in immune modulation and autonomic signaling rather than direct pain masking.\\n\\n## Why VIP might help you\\nIf immune or autonomic layers contribute to your nerve damage, VIP is discussed because it is examined for tissue-level repair effects in those systems. Step 1: Injury can trigger VIP expression changes in sensory and sympathetic fibers. Step 2: Those fibers help regulate local blood flow to the nerve. Step 3: VIP may influence inflammatory cell behavior and support conditions for regeneration instead of simply dampening symptoms.\\n\\n## How these fit together\\nSingle-compound focus. VIP is examined for the immune/autonomic layer. If your profile involves multiple peptides, siblings would target other layers such as direct structural repair or sleep-related recovery.\\n\\n## What the evidence actually shows\\nPreclinical (rat) studies show increased VIP levels after sciatic nerve injury and repair, with greater rises in unrepaired segments (Rayan 1991, pubmed.ncbi.nlm.nih.gov/1791362/). Another rat study found VIP and nerve growth factor both affected regeneration metrics in 60 sciatic nerves (Rayan 1995). In spared-nerve-injury mice, VIP deficiency altered immune responses to the lesion (2024 study). VIP reduced ischemic brain damage and apoptosis markers in rats (Yang 2011). VIP prevented collagen-induced arthritis progression in mice via reduced inflammatory infiltrate and cartilage damage (Delgado 2001, summarized in hopkinsarthritis.org). No large human ","tokens_in":14476,"tokens_out":2637,"cost":0,"prev":"genesis","hash":"333b3e05ecc97c3c8fda5fb0194f54554f3c54fb71f153d9e0b9773d548ceb76"},{"ts":"2026-07-17T02:43:25.455Z","model":"owner","action":"voxel_divide","prompt":"","input":"vip-nerve-damage","response":"18 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"333b3e05ecc97c3c8fda5fb0194f54554f3c54fb71f153d9e0b9773d548ceb76","hash":"fd5ed8c2c7ecb6cdfeede618332a5bcd764bb30b51dd75d6db66f29f06e4c475"}]}